Wang Huei-Shyong, Kuo Meng-Fai
Division of Pediatric Neurology, Chang Gung Children's Hospital, Taipei, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Chang Gung Med J. 2007 Sep-Oct;30(5):396-401.
In some patients without vitamin B6 deficiency, epilepsy can not be controlled without an extra supplement of vitamin B6. The therapeutic role of pyridoxal phosphate (PLP), the active form of vitamin B6, may not be replaced with other forms of vitamin B6 sometimes. Until now, four inborn errors of metabolism are known to affect vitamin B6 concentrations in the brain. Three of them are hyperprolinemia type 2, antiquitin deficiency, and pyridoxine phosphate oxidase deficiency. The fourth disorder occurs in neonates with hypophosphatasia and congenital rickets. All patients with these conditions present with early-onset epilepsy that is resistant to conventional antiepileptic medications. Patients with three of the conditions respond to any form of vitamin B6. Only those with pyridoxine phosphate oxidase deficiency respond to PLP instead of pyridoxine. Interestingly, the authors have successfully treated many patients without the above four disorders using vitamin B6, and have found that the treatment was more effective with PLP than with pyridoxine, though the mechanism is not known. Since PLP is as inexpensive as pyridoxine, we suggest replacing PLP for pyridoxine when treating children with epilepsy.
在一些没有维生素B6缺乏的患者中,不额外补充维生素B6就无法控制癫痫。维生素B6的活性形式磷酸吡哆醛(PLP)的治疗作用有时无法被其他形式的维生素B6替代。到目前为止,已知有四种先天性代谢缺陷会影响大脑中的维生素B6浓度。其中三种是2型高脯氨酸血症、抗喹啉缺乏症和磷酸吡哆醇氧化酶缺乏症。第四种疾病发生在患有低磷酸酯酶症和先天性佝偻病的新生儿中。所有患有这些病症的患者都表现出对传统抗癫痫药物耐药的早发性癫痫。患有其中三种病症的患者对任何形式的维生素B6都有反应。只有磷酸吡哆醇氧化酶缺乏症患者对PLP有反应,而对吡哆醇无反应。有趣的是,作者用维生素B6成功治疗了许多没有上述四种病症的患者,并且发现PLP治疗比吡哆醇更有效,尽管其机制尚不清楚。由于PLP与吡哆醇价格一样便宜,我们建议在治疗癫痫儿童时用PLP替代吡哆醇。